Lexaria Bioscience (LEXX) Capital Leases (2021 - 2024)
Lexaria Bioscience (LEXX) posted Capital Leases of $109319.0 for Q3 2024, down 5.21% sequentially from $115327.0 in Q2 2024, and down 19.72% YoY from $136173.0 in Q3 2023.
Lexaria Bioscience (LEXX) Capital Leases (2021 - 2024) Analysis & Trends
Lexaria Bioscience has reported Capital Leases for 4 years, with the latest figure at $109319.0 in Q3 2024.
- Quarterly Capital Leases fell 19.72% year-over-year to $109319.0 in Q3 2024, while the trailing twelve-month figure through Aug 2024 was $109319.0 (down 19.72% YoY) and the FY2024 annual result came in at $109319.0, down 19.72% from the prior year.
- Capital Leases fell to $109319.0 in Q3 2024 per LEXX's latest filing, from $115327.0 in the prior quarter.
- Over five years, Capital Leases peaked at $142587.0 in Q2 2023 and troughed at $7401.0 in Q3 2022.
- A 4-year average of $101599.9 and a median of $118906.5 in 2024 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2022 and 2023: Capital Leases slumped 85.19% in 2022, then surged 1739.93% in 2023.
- Over 4 years, Capital Leases stood at $49989.0 in 2021, then plunged by 85.19% to $7401.0 in 2022, then soared by 1649.99% to $129517.0 in 2023, then slipped by 15.59% to $109319.0 in 2024.
- According to Business Quant data, Capital Leases over the past three periods registered $109319.0, $115327.0, and $122486.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Lexaria Bioscience | 10.19 Mn | 6.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2024 | 109,319.00 |
| May 31, 2024 | 115,327.00 |
| Feb 29, 2024 | 122,486.00 |
| Nov 30, 2023 | 129,517.00 |
| Aug 31, 2023 | 136,173.00 |
| May 31, 2023 | 142,587.00 |
| Aug 31, 2022 | 7,401.00 |
| Aug 31, 2021 | 49,989.00 |